{"id":3440,"date":"2022-07-13T14:11:59","date_gmt":"2022-07-13T12:11:59","guid":{"rendered":"https:\/\/reseau-amylose.org\/rechercheamylose\/?page_id=3440"},"modified":"2022-07-18T14:52:33","modified_gmt":"2022-07-18T12:52:33","slug":"publications","status":"publish","type":"page","link":"https:\/\/reseau-amylose.org\/rechercheamylose\/publications\/","title":{"rendered":"Publications"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"3440\" class=\"elementor elementor-3440\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-2e06d752 elementor-section-content-middle elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"2e06d752\" data-element_type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-no\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-5044e89a\" data-id=\"5044e89a\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8d069ac elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"8d069ac\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-57a14359 elementor-widget elementor-widget-heading\" data-id=\"57a14359\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Articles publi\u00e9s par les experts du R\u00e9seau Amylose<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-3d94ca2 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"3d94ca2\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b93d0a2\" data-id=\"b93d0a2\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a4afe38 elementor-widget elementor-widget-text-editor\" data-id=\"a4afe38\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h6><span style=\"color: #000000\">Consultez les articles publi\u00e9s par les experts du R\u00e9seau Amylose. le num\u00e9ro PMID vous permet de retrouver l&rsquo;article et le lien pubmed de le consulter en ligne.<\/span><\/h6><h6><span style=\"color: #000000\">Pour retrouver un article dans ce tableau, s\u00e9lectionnez sur votre clavier \u00ab\u00a0ctrl + F\u00a0\u00bb et tapez des mots cl\u00e9s de l&rsquo;article ou son num\u00e9ro PMID.<\/span><\/h6><h6 style=\"text-align: left\">Ce tableau, mis \u00e0 jour chaque ann\u00e9e, r\u00e9pertorie les articles du site <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/\" target=\"_blank\" rel=\"noopener\">PUBMED.<\/a><\/h6><h6 style=\"text-align: left\">Pour compl\u00e9ter ce tableau, nous avons int\u00e9gr\u00e9 dans le moteur de recherche \u00ab\u00a0Nom de l&rsquo;expert premi\u00e8re lettre du pr\u00e9nom and cardiac amyloidosis\u00a0\u00bb exemple : \u00ab\u00a0lairez o and cardiac amyloidosis\u00a0\u00bb<\/h6>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-bb06ff5 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"bb06ff5\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-21ebfd3\" data-id=\"21ebfd3\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d6097a2 elementor-widget elementor-widget-text-editor\" data-id=\"d6097a2\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<table width=\"1541\"><tbody><tr><td width=\"87\">PMID<\/td><td width=\"389\">Title<\/td><td width=\"391\">Authors<\/td><td width=\"191\">Citation<\/td><td width=\"115\">First Author<\/td><td width=\"368\">lien PUBMED<\/td><\/tr><tr><td>35747521<\/td><td width=\"389\">Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis<\/td><td width=\"391\">Guendouz S, Grimbert P, Radu C, Cherqui D, Salloum C, Mongardon N, Maghrebi S, Belhadj K, Le Bras F, Teiger E, Couetil JP, Balan A, Kharoubi M, B\u00e9zard M, Oghina S, Bodez D, Hittinger L, Audard V, Plant\u00e9-Bordeneuve V, De la Taille A, Bergoend E, Frenkel V, Fanen P, Leroy V, Duvoux C, Carmagnat M, Folliguet T, Damy T.<\/td><td>Transplant Direct<\/td><td>\u00a02022 Jun 17<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35747521\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35747521\/<\/a><\/td><\/tr><tr><td>35734274<\/td><td width=\"389\">Diagnostic and Prognostic Values of Cardiopulmonary Exercise Testing in Cardiac Amyloidosis<\/td><td width=\"391\">Banydeen R, Monfort A, Inamo J, Neviere R.<\/td><td>Front Cardiovasc Med<\/td><td>\u00a02022 Jun 6<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35734274\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35734274\/<\/a><\/td><\/tr><tr><td>35717381<\/td><td width=\"389\">Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update<\/td><td width=\"391\">Dispenzieri A, Coelho T, Concei\u00e7\u00e3o I, Waddington-Cruz M, Wixner J, Kristen AV, Rapezzi C, Plant\u00e9-Bordeneuve V, Gonzalez-Moreno J, Maurer MS, Grogan M, Chapman D, Amass L<\/td><td>Orphanet J Rare Dis<\/td><td>2022 jun<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35717381\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35717381\/<\/a><\/td><\/tr><tr><td>35665045<\/td><td width=\"389\">Cerebral Ischemic Events: An Overlooked Complication of Transthyretin Cardiac Amyloidosis in Afro-Caribbean Patients<\/td><td width=\"391\">Banydeen R, Signate A, Tran TH, Monfort A, Neviere R, Inamo J.<\/td><td>Front Neurol<\/td><td>\u00a02022 May 19<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35665045\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35665045\/<\/a><\/td><\/tr><tr><td>35652845<\/td><td width=\"389\">Amylose cardiaque dite s\u00e9nile\u00a0: diagnostic et nouvelles perspectives th\u00e9rapeutiques<\/td><td width=\"391\">Berrut G, Piriou N, Boureau AS, Hanon O, Trochu JN.<\/td><td>Geriatr Psychol Neuropsychiatr Vieil<\/td><td>\u00a02022 Mar 1<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35652845\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35652845\/<\/a><\/td><\/tr><tr><td>35608040<\/td><td width=\"389\">Characteristics and natural history of early-stage cardiac transthyretin amyloidosis<\/td><td width=\"391\">Law S, Bezard M, Petrie A, Chacko L, Cohen OC, Ravichandran S, Ogunbiyi O, Kharoubi M, Ganeshananthan S, Ganeshananthan S, Gilbertson JA, Rowczenio D, Wechalekar A, Martinez-Naharro A, Lachmann HJ, Whelan CJ, Hutt DF, Hawkins PN, Damy T, Fontana M, Gillmore JD.<\/td><td>Eur Heart J<\/td><td>2022 May 24<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35608040\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35608040\/<\/a><\/td><\/tr><tr><td>35583798<\/td><td width=\"389\">Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)<\/td><td width=\"391\">Campbell CM, LoRusso S, Dispenzieri A, Kristen AV, Maurer MS, Rapezzi C, Lairez O, Drachman B, Garcia-Pavia P, Grogan M, Chapman D, Amass L<\/td><td>Cardiol Ther<\/td><td>2022 May<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35583798\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35583798\/<\/a><\/td><\/tr><tr><td>35346209<\/td><td width=\"389\">Pulmonary 99mTc-HMDP uptake correlates with restrictive ventilatory defects and abnormal lung reactance in transthyretin cardiac amyloidosis patients<\/td><td width=\"391\">Monfort A, Rivas A, Banydeen R, Inamo J, Farid K, Neviere R.<\/td><td>Respir Res<\/td><td>2022 Mar 27<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35346209\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35346209\/<\/a><\/td><\/tr><tr><td>35184821<\/td><td width=\"389\">Cardiac imaging in infiltrative cardiomyopathies. What cardiovascular imaging modalities to propose in hypertrophic cardiomyopathies\u00a0?<\/td><td width=\"391\">Pasteur-Rousseau A, Odouard S, Souibri K, Sebag FA, Deux JF, Damy T.<\/td><td>Ann Cardiol Angeiol (Paris)<\/td><td>2022 Apr<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35184821\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35184821\/<\/a><\/td><\/tr><tr><td>35144512<\/td><td width=\"389\">Amyloidosis from the patient perspective: the French daily impact of amyloidosis study<\/td><td width=\"391\">Damy T, Adams D, Bridoux F, Grateau G, Plant\u00e9-Bordeneuve V, Ghiron Y, Farrugia A, Pelcot F, Taieb C, Labeyrie C, Jaccard A, Georgin-Lavialle S.<\/td><td>Amyloid<\/td><td>2022 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35144512\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35144512\/<\/a><\/td><\/tr><tr><td>35128833<\/td><td width=\"389\">Prevalence and determinants of iron deficiency in cardiac amyloidosis<\/td><td width=\"391\">Jobb\u00e9-Duval A, B\u00e9zard M, Moutereau S, Kharoubi M, Oghina S, Zaroui A, Galat A, Chalard C, Hugon-Vallet E, Lemonnier F, Eyharts D, Poulot E, Fanen P, Funalot B, Molinier-Frenkel V, Audard V, Hittinger L, Delbarre MA, Teiger E, Damy T.<\/td><td>ESC Heart Fail<\/td><td>\u00a02022 Apr<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35128833\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35128833\/<\/a><\/td><\/tr><tr><td>35114877<\/td><td width=\"389\">Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival<\/td><td width=\"391\">Kharoubi M, Bodez D, B\u00e9zard M, Zaroui A, Galat A, Guendouz S, Gendre T, Hittinger L, Attias D, Mohty D, Bergoend E, Itti E, Lebras F, Hamon D, Poullot E, Molinier-Frenkel V, Lellouche N, Deux JF, Funalot B, Fannen P, Oghina S, Arrouasse R, Lecorvoisier P, Souvannanorath S, Amiot A, Teiger E, Bougouin W, Damy T.<\/td><td>Amyloid<\/td><td>2022 Jun<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35114877\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35114877\/<\/a><\/td><\/tr><tr><td>34996829<\/td><td width=\"389\">Restrictive spirometry pattern and abnormal cardiopulmonary response to exercise in transthyretin cardiac amyloidosis<\/td><td width=\"391\">Banydeen R, Vergaro G, Deney A, Monfort A, Emdin M, Lairez O, Giguet AG, Inamo J, Neviere R.<\/td><td>Eur Respir J<\/td><td>2022 Feb 24<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34996829\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34996829\/<\/a><\/td><\/tr><tr><td>34917658<\/td><td width=\"389\">New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact<\/td><td width=\"391\">Cariou E, Sanchis K, Rguez K, Blanchard V, Cazalbou S, Fournier P, Huart A, Roussel M, Cintas P, Galinier M, Carri\u00e9 D, Maury P, Lavie-Badie Y, Lairez O.<\/td><td>Front Cardiovasc Med<\/td><td>2021 Nov 30<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34917658\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34917658\/<\/a><\/td><\/tr><tr><td>34841715<\/td><td width=\"389\">(99m) Technetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy<\/td><td width=\"391\">Tahara N, Lairez O, Endo J, Okada A, Ueda M, Ishii T, Kitano Y, Lee HE, Russo E, Kubo T.<\/td><td>ESC Heart Fail<\/td><td>2022 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34841715\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34841715\/<\/a><\/td><\/tr><tr><td>34823661<\/td><td width=\"389\">Assessing Cardiac Amyloidosis Subtypes\u00a0by Unsupervised Phenotype Clustering Analysis<\/td><td width=\"391\">Bonnefous L, Kharoubi M, B\u00e9zard M, Oghina S, Le Bras F, Poullot E, Molinier-Frenkel V, Fanen P, Deux JF, Audard V, Itti E, Damy T, Audureau E.<\/td><td>J Am Coll Cardiol<\/td><td>2021 Nov 30<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34823661\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34823661\/<\/a><\/td><\/tr><tr><td>34784656<\/td><td width=\"389\">Thromboembolism and bleeding in systemic amyloidosis: a review<\/td><td width=\"391\">Nicol M, Siguret V, Vergaro G, Aimo A, Emdin M, Dillinger JG, Baudet M, Cohen-Solal A, Villesuzanne C, Harel S, Royer B, Arnulf B, Logeart D.<\/td><td>ESC Heart Fail<\/td><td>2022 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34784656\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34784656\/<\/a><\/td><\/tr><tr><td>34779246<\/td><td width=\"389\">Tafamidis and quality of life in people with transthyretin amyloid cardiomyopathy in the study ATTR-ACT: A plain language summary<\/td><td width=\"391\">Hanna M, Damy T, Grogan M, Stewart M, Gundapaneni B, Sultan MB, Maurer MS.<\/td><td>Future Cardiol<\/td><td>2022 Mar<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34779246\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34779246\/<\/a><\/td><\/tr><tr><td>34768408<\/td><td width=\"389\">Echocardiographic Patterns of Left Ventricular Diastolic Function in Cardiac Amyloidosis: An Updated Evaluation<\/td><td width=\"391\">Oghina S, Bougouin W, Kharoubi M, Bonnefous L, Galat A, Guendouz S, Bezard M, Le Bras F, Deux JF, Itti E, Moktefi A, Fanen P, Teiger E, Mohty D, Damy T, Bodez D.<\/td><td>J Clin Med<\/td><td>2021 Oct 23<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34768408\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34768408\/<\/a><\/td><\/tr><tr><td>34768388<\/td><td width=\"389\">Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels in the Natural History of Transthyretin Amyloid Cardiomyopathy and Their Evolution after Tafamidis Treatment<\/td><td width=\"391\">Oghina S, Josse C, B\u00e9zard M, Kharoubi M, Delbarre MA, Eyharts D, Zaroui A, Guendouz S, Galat A, Hittinger L, Fanen P, Teiger E, Mouri N, Montestruc F, Damy T.<\/td><td>J Clin Med<\/td><td>2021 Oct 22<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34768388\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34768388\/<\/a><\/td><\/tr><tr><td>34734471<\/td><td width=\"389\">Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis<\/td><td width=\"391\">Fischer K, Lellouche N, Damy T, Martins R, Clementy N, Bisson A, Lesaffre F, Espinosa M, Garcia R, Degand B, Serzian G, Jourda F, Huttin O, Guichard JB, Devilliers H, Eicher JC, Laurent G, Guenancia C.<\/td><td>ESC Heart Fail<\/td><td>2022 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34734471\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34734471\/<\/a><\/td><\/tr><tr><td>34729526<\/td><td width=\"389\">Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey<\/td><td width=\"391\">Nativi-Nicolau J, Siu A, Dispenzieri A, Maurer MS, Rapezzi C, Kristen AV, Garcia-Pavia P, LoRusso S, Waddington-Cruz M, Lairez O, Witteles R, Chapman D, Amass L, Grogan M<\/td><td>JACC CardioOncol<\/td><td>2021 Oct<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34729526\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34729526\/<\/a><\/td><\/tr><tr><td>34714605<\/td><td width=\"389\">History of extracardiac\/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis<\/td><td width=\"391\">Kharoubi M, B\u00e9zard M, Galat A, Le Bras F, Poullot E, Molinier-Frenkel V, Fanen P, Funalot B, Moktefi A, Lefaucheur JP, Abulizi M, Deux JF, Lemonnier F, Guendouz S, Chalard C, Zaroui A, Audard V, Bequignon E, Bodez D, Itti E, Hittinger L, Audureau E, Teiger E, Oghina S, Damy T.<\/td><td>ESC Heart Fail<\/td><td>2021 Dec<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34714605\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34714605\/<\/a><\/td><\/tr><tr><td>34643339<\/td><td width=\"389\">Impact of tricuspid regurgitation on survival in patients with cardiac amyloidosis<\/td><td width=\"391\">Fagot J, Lavie-Badie Y, Blanchard V, Fournier P, Galinier M, Carri\u00e9 D, Lairez O, Cariou E<\/td><td>ESC Heart Fail<\/td><td>2021 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34643339\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34643339\/<\/a><\/td><\/tr><tr><td>34602081<\/td><td width=\"389\">Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression<\/td><td width=\"391\">Adams D, Algalarrondo V, Polydefkis M, Sarswat N, Slama MS, Nativi-Nicolau J.<\/td><td>Orphanet J Rare Dis<\/td><td>2021 Oct 3<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34602081\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34602081\/<\/a><\/td><\/tr><tr><td>34525116<\/td><td width=\"389\">Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement<\/td><td width=\"391\">B\u00e9zard M, Oghina S, Vitiello D, Kharoubi M, Kordeli E, Galat A, Zaroui A, Guendouz S, Gilles F, Shourick J, Hamon D, Audard V, Teiger E, Poullot E, Molinier-Frenkel V, Lemonnier F, Agbulut O, Le Bras F, Damy T.<\/td><td>PLoS One<\/td><td>2021 Sep 15<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34525116\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34525116\/<\/a><\/td><\/tr><tr><td>34490695<\/td><td width=\"389\">AA amyloidosis complicating monoclonal gammopathies, an unusual feature validating the concept of \u00ab\u00a0monoclonal gammopathy of inflammatory significance\u00a0\u00bb?<\/td><td width=\"391\">Terr\u00e9 A, Colombat M, Cez A, Martin C, Diet C, Brechignac S, Oghina S, Bodez D, Faguer S, Savey L, Galland J, Boffa JJ, Grateau G, Jaccard A, Buob D, Georgin-Lavialle S.<\/td><td>Int J Clin Pract<\/td><td>2021 Nov<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34490695\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34490695\/<\/a><\/td><\/tr><tr><td>34391735<\/td><td width=\"389\">Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS<\/td><td width=\"391\">Caponetti AG, Rapezzi C, Gagliardi C, Milandri A, Dispenzieri A, Kristen AV, Wixner J, Maurer MS, Garcia-Pavia P, Tournev I, Plant\u00e9-Bordeneuve V, Chapman D, Amass L<\/td><td>JACC Heart Fail<\/td><td>2021 Oct<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34391735\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34391735\/<\/a><\/td><\/tr><tr><td>34362197<\/td><td width=\"389\">Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg<\/td><td width=\"391\">Broussier A, David JP, Kharoubi M, Oghina S, Segaux L, Teiger E, Laurent M, Fromentin I, Bastuji-Garin S, Damy T.<\/td><td>J Clin Med<\/td><td>2021 Jul 31<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34362197\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34362197\/<\/a><\/td><\/tr><tr><td>34274113<\/td><td width=\"389\">Diagnosis and management of heart failure from hospital admission to discharge: A practical expert guidance<\/td><td width=\"391\">Sabouret P, Attias D, Beauvais C, Berthelot E, Bouleti C, Gibault Genty G, Galat A, Hanon O, Hulot JS, Isnard R, Jourdain P, Lamblin N, Lebreton G, Lellouche N, Logeart D, Meune C, Pezel T, Damy T.<\/td><td>Ann Cardiol Angeiol (Paris)<\/td><td>2022 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34274113\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34274113\/<\/a><\/td><\/tr><tr><td>34230094<\/td><td width=\"389\">Adaptive servo ventilation for sleep apnoea in heart failure: the FACE study 3-month data<\/td><td width=\"391\">Tamisier R, Damy T, Bailly S, Davy JM, Verbraecken J, Lavergne F, Palot A, Goutorbe F, d&rsquo;Ortho MP, P\u00e9pin JL<\/td><td width=\"191\">Thorax<\/td><td>2022 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34230094\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34230094\/<\/a><\/td><\/tr><tr><td>34173675<\/td><td width=\"389\">First symptoms and health care pathways in hospitalized patients with acute heart failure: ICPS2 survey. A report from the Heart Failure Working Group (GICC) of the French Society of Cardiology<\/td><td width=\"391\">Beauvais F, Tarti\u00e8re L, Pezel T, Motet C, Aumont MC, Baudry G, Eicher JC, Galinier M, Gellen B, Guihaire J, Legallois D, Lequeux B, Mika D, Mouquet F, Salvat M, Taieb C, Zor\u00e8s F, Berthelot E, Damy T.<\/td><td>Clin Cardiol<\/td><td>\u00a02021 Aug<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34173675\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34173675\/<\/a><\/td><\/tr><tr><td>34100681<\/td><td width=\"389\">Diagnostic Value of Extracellular Volume Quantification and Myocardial Perfusion Analysis at CT in Cardiac Amyloidosis<\/td><td width=\"391\">Deux JF, Nouri R, Tacher V, Zaroui A, Derbel H, Sifaoui I, Chevance V, Ridouani F, Galat A, Kharoubi M, Oghina S, Guendouz S, Audureau E, Teiger E, Kobeiter H, Damy T.<\/td><td>Radiology<\/td><td>\u00a02021 Aug<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34100681\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34100681\/<\/a><\/td><\/tr><tr><td>34089308<\/td><td width=\"389\">Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature<\/td><td width=\"391\">Adam RD, Coriu D, Jercan A, B\u0103deli\u0163\u0103 S, Popescu BA, Damy T, Jurcu\u0163 R.<\/td><td>ESC Heart Fail<\/td><td>\u00a02021 Aug<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34089308\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34089308\/<\/a><\/td><\/tr><tr><td>34042016<\/td><td width=\"389\">A simple core dataset and disease severity score for hereditary transthyretin (ATTRv) amyloidosis<\/td><td width=\"391\">Damy T, Concei\u00e7\u00e3o I, Garc\u00eda-Pav\u00eda P, Gillmore J, Jandhyala R, Sabbat J, Wixner J, Coelho T.<\/td><td>Amyloid<\/td><td>\u00a02021 Sep<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34042016\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34042016\/<\/a><\/td><\/tr><tr><td>34035264<\/td><td width=\"389\">A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells<\/td><td width=\"391\">Michalon A, Hagenbuch A, Huy C, Varela E, Combaluzier B, Damy T, Suhr OB, Saraiva MJ, Hock C, Nitsch RM, Jan Grimm.<\/td><td>Nat Commun<\/td><td>\u00a02021 May 25<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34035264\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34035264\/<\/a><\/td><\/tr><tr><td>34024024<\/td><td width=\"389\">Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)<\/td><td width=\"391\">Waddington-Cruz M, Wixner J, Amass L, Kiszko J, Chapman D, Ando Y<\/td><td width=\"191\">Neurol Ther<\/td><td>2021 Dec<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34024024\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34024024\/<\/a><\/td><\/tr><tr><td>33980765<\/td><td width=\"389\">Value of Longitudinal Strain to Identify Wild-Type Transthyretin Amyloidosis in Patients With Aortic Stenosis<\/td><td width=\"391\">Robin G, Cognet T, Bouisset F, Cariou E, M\u00e9jean S, Pradel S, Colombat M, Galinier M, Carri\u00e9 D, Lairez O<\/td><td width=\"191\">Circ J<\/td><td>2021 Aug<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33980765\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33980765\/<\/a><\/td><\/tr><tr><td>33957949<\/td><td width=\"389\">ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable<\/td><td width=\"391\">Brannagan TH 3rd, Auer-Grumbach M, Berk JL, Briani C, Bril V, Coelho T, Damy T, Dispenzieri A, Drachman BM, Fine N, Gaggin HK, Gertz M, Gillmore JD, Gonzalez E, Hanna M, Hurwitz DR, Khella SL, Maurer MS, Nativi-Nicolau J, Olugemo K, Quintana LF, Rosen AM, Schmidt HH, Shehata J, Waddington-Cruz M, Whelan C, Ruberg FL.<\/td><td>Orphanet J Rare Dis<\/td><td>\u00a02021 May 6<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33957949\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33957949\/<\/a><\/td><\/tr><tr><td>33933023<\/td><td width=\"389\">Good performance in the management of acute heart failure in cardiogeriatric departments: the ICREX-94 experience<\/td><td width=\"391\">Berthelot E, Broussier A, Damy T, Donadio C, Cosson S, Rovani X, Salengro E, Billebeau G, Megbemado R, Rekik N, Godreuil C, Richard K, Shourick J, Assayag P, Belmin J, David JP, Hittinger L<\/td><td>BMC Geriatr<\/td><td>2021 May<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33933023\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33933023\/<\/a><\/td><\/tr><tr><td>33915002<\/td><td width=\"389\">Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy<\/td><td width=\"391\">Garcia-Pavia P, Bengel F, Brito D, Damy T, Duca F, Dorbala S, Nativi-Nicolau J, Obici L, Rapezzi C, Sekijima Y, Elliott PM.<\/td><td>Eur J Heart Fail<\/td><td>\u00a02021 Jun<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33915002\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33915002\/<\/a><\/td><\/tr><tr><td>33826207<\/td><td width=\"389\">Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases<\/td><td width=\"391\">Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, Fontana M, Gillmore JD, Gonzalez-Lopez E, Grogan M, Heymans S, Imazio M, Kindermann I, Kristen AV, Maurer MS, Merlini G, Pantazis A, Pankuweit S, Rigopoulos AG, Linhart A.<\/td><td>Eur J Heart Fail<\/td><td>\u00a02021 Apr<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33826207\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33826207\/<\/a><\/td><\/tr><tr><td>33825853<\/td><td width=\"389\">Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases<\/td><td width=\"391\">Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, Fontana M, Gillmore JD, Gonzalez-Lopez E, Grogan M, Heymans S, Imazio M, Kindermann I, Kristen AV, Maurer MS, Merlini G, Pantazis A, Pankuweit S, Rigopoulos AG, Linhart A.<\/td><td>Eur Heart J<\/td><td>\u00a02021 Apr 21<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33825853\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33825853\/<\/a><\/td><\/tr><tr><td>33713427<\/td><td width=\"389\">Venetoclax induces profound and sustained responses in patients with relapsed\/refractory light-chain amyloidosis<\/td><td width=\"391\">Pasquer H, Belhadj K, Dupuis J, Oghina S, Galat A, Ladaique A, Maarek A, Roulin L, Gounot R, Poulot E, Beldi-Ferchiou A, Molinier-Frenkel V, Haioun C, Damy T, Le Bras F, Lemonnier F.<\/td><td>Br J Haematol<\/td><td>\u00a02021 May<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33713427\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33713427\/<\/a><\/td><\/tr><tr><td>33619905<\/td><td width=\"389\">Diagnosis and Treatment of Iron Deficiency in Heart Failure: OFICSel study by the French Heart Failure Working Group<\/td><td width=\"391\">Pezel T, Audureau E, Mansourati J, Baudry G, Ben Driss A, Durup F, Fertin M, Godreuil C, Jeanneteau J, Kloeckner M, Koukoui F, Kesri-Tarti\u00e8re L, Laperche T, Roubille F, Cohen-Solal A, Damy T.<\/td><td>ESC Heart Fail<\/td><td>\u00a02021 Apr<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33619905\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33619905\/<\/a><\/td><\/tr><tr><td>33549560<\/td><td width=\"389\">The Impact of Patients With Cardiac\u00a0Amyloidosis in HFpEF Trials<\/td><td width=\"391\">Oghina S, Bougouin W, B\u00e9zard M, Kharoubi M, Komajda M, Cohen-Solal A, Mebazaa A, Damy T, Bodez D.<\/td><td>JACC Heart Fail<\/td><td>\u00a02021 Mar<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33549560\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33549560\/<\/a><\/td><\/tr><tr><td>33441470<\/td><td width=\"389\">Tip of the iceberg: a tertiary care centre retrospective study of left ventricular hypertrophy aetiologies<\/td><td width=\"391\">Beneyto M, Cariou E, Brunel J, Scripcariu A, Delasnerie H, Brun S, Lavie-Badie Y, Dupin Deguine D, Galinier M, Carri\u00e9 D, Lairez O.<\/td><td>Open Heart<\/td><td>\u00a02021 Jan<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33441470\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33441470\/<\/a><\/td><\/tr><tr><td>33422349<\/td><td width=\"389\">Cardiac amyloidosis<\/td><td width=\"391\">Poullot E, Oghina S, Kalsoum S, Damy T.<\/td><td>Ann Pathol<\/td><td>\u00a02021 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33422349\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33422349\/<\/a><\/td><\/tr><tr><td>33354901<\/td><td width=\"389\">Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan\u00ae in transthyretin wild-type cardiac amyloidosis<\/td><td width=\"391\">Kharoubi M, Roche F, B\u00e9zard M, Hupin D, Silva S, Oghina S, Chalard C, Zaroui A, Galat A, Guendouz S, Canoui-Poitrine F, Hittinger L, Teiger E, Lefaucheur JP, Damy T.<\/td><td>ESC Heart Fail<\/td><td>\u00a02021 Apr<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33354901\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33354901\/<\/a><\/td><\/tr><tr><td>33340199<\/td><td width=\"389\">Reply to the letter regarding the article &lsquo;Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study&rsquo;<\/td><td width=\"391\">Damy T, Sultan MB, Witteles R.<\/td><td>Eur J Heart Fail<\/td><td>\u00a02021 Jun<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33340199\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33340199\/<\/a><\/td><\/tr><tr><td>33309574<\/td><td width=\"389\">Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT<\/td><td width=\"391\">Rapezzi C, Elliott P, Damy T, Nativi-Nicolau J, Berk JL, Velazquez EJ, Boman K, Gundapaneni B, Patterson TA, Schwartz JH, Sultan MB, Maurer MS.<\/td><td>JACC Heart Fail<\/td><td>\u00a02021 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33309574\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33309574\/<\/a><\/td><\/tr><tr><td>33251891<\/td><td width=\"389\">Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment<\/td><td width=\"391\">Gounot R, Le Bras F, Dupuis J, Oghina S, Bodez D, Roulin L, Maarek A, Ladaique A, Beldi-Ferchiou A, Poullot E, Molinier-Frenkel V, Haioun C, Damy T, Belhadj K, Lemonnier F.<\/td><td>Leuk Lymphoma<\/td><td>\u00a02021 Apr<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33251891\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33251891\/<\/a><\/td><\/tr><tr><td>33245757<\/td><td width=\"389\">New expectations for diastolic function assessment in transthoracic echocardiography based on a semi-automated computing of strain-volume loops<\/td><td width=\"391\">Hubert A, Le Rolle V, Galli E, Bidaud A, Hernandez A, Donal E.<\/td><td>Eur Heart J Cardiovasc Imaging<\/td><td>\u00a02020 Dec 1<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33245757\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33245757\/<\/a><\/td><\/tr><tr><td>33220323<\/td><td width=\"389\">Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)<\/td><td width=\"391\">Hanna M, Damy T, Grogan M, Stewart M, Gundapaneni B, Patterson TA, Schwartz JH, Sultan MB, Maurer MS.<\/td><td>Am J Cardiol<\/td><td>\u00a02021 Feb 15<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33220323\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33220323\/<\/a><\/td><\/tr><tr><td>33212063<\/td><td width=\"389\">Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study<\/td><td width=\"391\">Adams D, Polydefkis M, Gonz\u00e1lez-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada L\u00f3pez IA, Dispenzieri A, Quan D, Concei\u00e7\u00e3o IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Plant\u00e9-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T<\/td><td>Lancet Neurol<\/td><td>2021 Jan<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33212063\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33212063\/<\/a><\/td><\/tr><tr><td>33094885<\/td><td width=\"389\">Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis<\/td><td width=\"391\">B\u00e9zard M, Kharoubi M, Galat A, Poullot E, Guendouz S, Fanen P, Funalot B, Moktefi A, Lefaucheur JP, Abulizi M, Deux JF, Gendre T, Audard V, El Karoui K, Canoui-Poitrine F, Zaroui A, Itti E, Teiger E, Plant\u00e9-Bordeneuve V, Oghina S, Damy T.<\/td><td>Eur J Heart Fail<\/td><td>\u00a02021 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33094885\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33094885\/<\/a><\/td><\/tr><tr><td>33070419<\/td><td width=\"389\">Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study<\/td><td width=\"391\">Damy T, Garcia-Pavia P, Hanna M, Judge DP, Merlini G, Gundapaneni B, Patterson TA, Riley S, Schwartz JH, Sultan MB, Witteles R.<\/td><td>Eur J Heart Fail<\/td><td>\u00a02021 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33070419\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33070419\/<\/a><\/td><\/tr><tr><td>33067004<\/td><td width=\"389\">[Diagnosing cardiac amyloidosis in magnetic resonance imaging: The discriminating factors]<\/td><td width=\"391\">Go\u00eforani F, Dagrenat C, Brocchi J, Couppie P, Leddet P.<\/td><td>Ann Cardiol Angeiol (Paris)<\/td><td>\u00a02020 Nov<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33067004\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33067004\/<\/a><\/td><\/tr><tr><td>33051335<\/td><td width=\"389\">Can myocardial work indices contribute to the exploration of patients with cardiac amyloidosis?<\/td><td width=\"391\">Roger-Roll\u00e9 A, Cariou E, Rguez K, Fournier P, Lavie-Badie Y, Blanchard V, Roncalli J, Galinier M, Carri\u00e9 D, Lairez O<\/td><td>Open Heart<\/td><td>2020 Oct<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33051335\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33051335\/<\/a><\/td><\/tr><tr><td>33006180<\/td><td width=\"389\">Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis<\/td><td width=\"391\">Nicol M, Deney A, Lairez O, Vergaro G, Emdin M, Carecci A, Inamo J, Montfort A, Neviere R, Damy T, Harel S, Royer B, Baudet M, Cohen-Solal A, Arnulf B, Logeart D.<\/td><td>Eur J Heart Fail<\/td><td>\u00a02021 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33006180\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33006180\/<\/a><\/td><\/tr><tr><td>32967612<\/td><td width=\"389\">Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner<\/td><td width=\"391\">Gertz M, Adams D, Ando Y, Beir\u00e3o JM, Bokhari S, Coelho T, Comenzo RL, Damy T, Dorbala S, Drachman BM, Fontana M, Gillmore JD, Grogan M, Hawkins PN, Lousada I, Kristen AV, Ruberg FL, Suhr OB, Maurer MS, Nativi-Nicolau J, Quarta CC, Rapezzi C, Witteles R, Merlini G.<\/td><td>BMC Fam Pract<\/td><td>\u00a02020 Sep 23<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32967612\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32967612\/<\/a><\/td><\/tr><tr><td>32826087<\/td><td width=\"389\">Transthyretin cardiac amyloidosis<\/td><td width=\"391\">Eicher JC, Audia S, Damy T.<\/td><td>Rev Med Interne<\/td><td>\u00a02020 Oct<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32826087\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32826087\/<\/a><\/td><\/tr><tr><td>32738048<\/td><td width=\"389\">Aortic stenosis and amyloid heart disease: &lsquo;the 2A dangerous liaisons&rsquo;<\/td><td width=\"391\">Mohty D, Pibarot P, Damy T.<\/td><td>Eur Heart J<\/td><td>\u00a02020 Aug 1<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32738048\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32738048\/<\/a><\/td><\/tr><tr><td>32617488<\/td><td width=\"389\">Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy<\/td><td width=\"391\">Aouate D, Menet A, Bellevre D, Damy T, Marechaux S.<\/td><td>Eur Heart J Case Rep<\/td><td>\u00a02020 May 1<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32617488\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32617488\/<\/a><\/td><\/tr><tr><td>32588554<\/td><td width=\"389\">Gateway and journey of patients with cardiac amyloidosis<\/td><td width=\"391\">Dang D, Fournier P, Cariou E, Huart A, Ribes D, Cintas P, Roussel M, Colombat M, Lavie-Badie Y, Carri\u00e9 D, Galinier M, Lairez O.<\/td><td>ESC Heart Fail<\/td><td>\u00a02020 Oct<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32588554\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32588554\/<\/a><\/td><\/tr><tr><td>32456532<\/td><td width=\"389\">DISCOVERY: prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosis<\/td><td width=\"391\">Akinboboye O, Shah K, Warner AL, Damy T, Taylor HA, Gollob J, Powell C, Karsten V, Vest J, Maurer MS.<\/td><td>Amyloid<\/td><td>\u00a02020 Dec<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32456532\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32456532\/<\/a><\/td><\/tr><tr><td>32405988<\/td><td width=\"389\">(99m)Tc-labelled bone tracer myocardial quantification: About correlation with heart function<\/td><td width=\"391\">Blondet C, Schaeffer O, Hubel\u00e9 F, Roul GJ, Imperiale A, Namer IJ.<\/td><td>J Nucl Cardiol<\/td><td>\u00a02020 Aug<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32405988\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32405988\/<\/a><\/td><\/tr><tr><td>32385539<\/td><td width=\"389\">Characterization of Fabry Disease cardiac involvement according to longitudinal strain, cardiometabolic exercise test, and T1 mapping<\/td><td width=\"391\">R\u00e9ant P, Testet E, Reynaud A, Bourque C, Michaud M, Rooryck C, Goizet C, Lacombe D, de-Pr\u00e9cigout V, Peyrou J, Cochet H, Lafitte S.<\/td><td>Int J Cardiovasc Imaging<\/td><td>\u00a02020 Jul<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32385539\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32385539\/<\/a><\/td><\/tr><tr><td>32157431<\/td><td width=\"389\">Extracardiac soft tissue uptake, evidenced on early (99m)Tc-HMDP SPECT\/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value<\/td><td width=\"391\">Malka N, Abulizi M, Kharoubi M, Oghina S, Galat A, Le Bras F, Moktefi A, Guendouz S, Molinier-Frenkel V, Fanen P, Funalot B, Lefaucheur JP, Blanc-Durand P, Deux JF, Audard V, Bodez D, Itti E, Damy T.<\/td><td>Eur J Nucl Med Mol Imaging<\/td><td>\u00a02020 Sep<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32157431\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32157431\/<\/a><\/td><\/tr><tr><td>32036861<\/td><td width=\"389\">CCS\/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis<\/td><td width=\"391\">O&rsquo;Meara E, McDonald M, Chan M, Ducharme A, Ezekowitz JA, Giannetti N, Grzeslo A, Heckman GA, Howlett JG, Koshman SL, Lepage S, Mielniczuk LM, Moe GW, Swiggum E, Toma M, Virani SA, Zieroth S, De S, Matteau S, Parent MC, Asgar AW, Cohen G, Fine N, Davis M, Verma S, Cherney D, Abrams H, Al-Hesayen A, Cohen-Solal A, D&rsquo;Astous M, Delgado DH, Desplantie O, Estrella-Holder E, Green L, Haddad H, Harkness K, Hernandez AF, Kouz S, LeBlanc MH, Lee D, Masoudi FA, McKelvie RS, Rajda M, Ross HJ, Sussex B.<\/td><td>Can J Cardiol<\/td><td>\u00a02020 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32036861\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32036861\/<\/a><\/td><\/tr><tr><td>32024385<\/td><td width=\"389\">Restrictive cardiac phenotype as primary cause of impaired aerobic capacity in Afro-Caribbean patients with val122ile variant transthyretin amyloid cardiomyopathy<\/td><td width=\"391\">Monfort A, Banydeen R, Demoniere F, Courty B, Codiat R, Neviere R, Inamo J.<\/td><td>Amyloid<\/td><td>\u00a02020 Sep<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32024385\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32024385\/<\/a><\/td><\/tr><tr><td>32007555<\/td><td width=\"389\">Echocardiographic Evaluation of Left Ventricular Filling Pressure in Patients With Heart Failure With Preserved Ejection Fraction: Usefulness of Inferior Vena Cava Measurements and 2016 EACVI\/ASE Recommendations<\/td><td width=\"391\">Berthelot E, Jourdain P, Bailly MT, Bouchachi A, Gellen B, Rouquette A, Damy T, Herv\u00e9 P, Chemla D, Assayag P.<\/td><td>J Card Fail<\/td><td>\u00a02020 Jun<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32007555\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32007555\/<\/a><\/td><\/tr><tr><td>31949094<\/td><td width=\"389\">Conjunctival lymphangiectasia as a biomarker of severe systemic disease in Ser77Tyr hereditary transthyretin amyloidosis<\/td><td width=\"391\">Bunod R, Adams D, Cauquil C, Francou B, Labeyrie C, Bourenane H, Adam C, Algalarrondo V, Slama M, Darce-Bello M, Barreau E, Labetoulle M, Rousseau A.<\/td><td>Br J Ophthalmol<\/td><td>\u00a02020 Oct<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31949094\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/31949094\/<\/a><\/td><\/tr><tr><td>31873816<\/td><td width=\"389\">Quantification of myocardial (99m)Tc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis<\/td><td width=\"391\">Manrique A, Dudoignon D, Brun S, N&rsquo;Ganoa C, Cassol E, Legallois D, Lavie-Badie Y, Agostini D, Lairez O.<\/td><td>EJNMMI Res<\/td><td>\u00a02019 Dec 23<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31873816\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/31873816\/<\/a><\/td><\/tr><tr><td>31753206<\/td><td width=\"389\">Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week<\/td><td width=\"391\">Ternacle J, Krapf L, Mohty D, Magne J, Nguyen A, Galat A, Gallet R, Teiger E, C\u00f4t\u00e9 N, Clavel MA, Tournoux F, Pibarot P, Damy T.<\/td><td>J Am Coll Cardiol<\/td><td>\u00a02019 Nov 26<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31753206\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/31753206\/<\/a><\/td><\/tr><tr><td>31512197<\/td><td width=\"389\">(18)F-sodium fluoride PET\/MRI myocardial imaging in patients with suspected cardiac amyloidosis<\/td><td width=\"391\">Abulizi M, Sifaoui I, Wuliya-Gariepy M, Kharoubi M, Isra\u00ebl JM, Emsen B, Bodez D, Monnet A, Didierlaurent D, Tacher V, Luciani A, Damy T, Deux JF, Itti E.<\/td><td>J Nucl Cardiol<\/td><td>\u00a02021 Aug<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31512197\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/31512197\/<\/a><\/td><\/tr><tr><td>31502881<\/td><td width=\"389\">Association between hearing loss and hereditary ATTR amyloidosis<\/td><td width=\"391\">Bartier S, Bodez D, Kharoubi M, Guellich A, Canou\u00ef-Poitrine F, Chatelin V, Coste A, Damy T, B\u00e9quignon E.<\/td><td>Amyloid<\/td><td>\u00a02019 Dec<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31502881\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/31502881\/<\/a><\/td><\/tr><tr><td>31480867<\/td><td width=\"389\">Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis<\/td><td width=\"391\">Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M, Grogan M, Kristen AV, Lousada I, Nativi-Nicolau J, Cristina Quarta C, Rapezzi C, Ruberg FL, Witteles R, Merlini G.<\/td><td>Circ Heart Fail<\/td><td>\u00a02019 Sep<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31480867\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/31480867\/<\/a><\/td><\/tr><tr><td>31364411<\/td><td width=\"389\">Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational study<\/td><td width=\"391\">Bartier S, Bodez D, Kharoubi M, Canou\u00ef-Poitrine F, Chatelin V, Henrion C, Coste A, Damy T, B\u00e9quignon E.<\/td><td>Amyloid<\/td><td>\u00a02019 Dec<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31364411\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/31364411\/<\/a><\/td><\/tr><tr><td>31302046<\/td><td width=\"389\">Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice<\/td><td width=\"391\">Witteles RM, Bokhari S, Damy T, Elliott PM, Falk RH, Fine NM, Gospodinova M, Obici L, Rapezzi C, Garcia-Pavia P.<\/td><td>JACC Heart Fail<\/td><td>\u00a02019 Aug<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31302046\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/31302046\/<\/a><\/td><\/tr><tr><td>31292624<\/td><td width=\"389\">Diagnostic score of cardiac involvement in AL amyloidosis<\/td><td width=\"391\">Nicol M, Baudet M, Brun S, Harel S, Royer B, Vignon M, Lairez O, Lavergne D, Jaccard A, Attias D, Macron L, Gayat E, Cohen-Solal A, Arnulf B, Logeart D.<\/td><td>Eur Heart J Cardiovasc Imaging<\/td><td>\u00a02020 May 1<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31292624\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/31292624\/<\/a><\/td><\/tr><tr><td>31217996<\/td><td width=\"389\">Value of natriuretic peptides and tissue Doppler imaging in the estimation of left ventricular filling pressure in patients with cardiac amyloidosis<\/td><td width=\"391\">Brun S, Cariou E, Fournier P, Ribes D, Faguer S, Huart A, Carri\u00e9 D, Galinier M, Lairez O<\/td><td>Open Heart<\/td><td>2019 May<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31217996\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/31217996\/<\/a><\/td><\/tr><tr><td>31183088<\/td><td width=\"389\">Light chain lambda myeloma with fatal AL cardiac amyloidosis in a 21-year-old patient: A case report and review<\/td><td width=\"391\">Camus V, Dubois S, Thi\u00e9baut PA, Lepretre S, Lenain P, Picquenot JM, Veresezan EL, Fran\u00e7ois A, Penther D, Bauer F, Jaccard A, Jardin F.<\/td><td>Clin Case Rep<\/td><td>\u00a02019 May 7<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31183088\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/31183088\/<\/a><\/td><\/tr><tr><td>31172799<\/td><td width=\"389\">Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality<\/td><td width=\"391\">Sanchis K, Cariou E, Colombat M, Ribes D, Huart A, Cintas P, Fournier P, Rollin A, Carri\u00e9 D, Galinier M, Maury P, Duparc A, Lairez O<\/td><td>Amyloid<\/td><td>2019 sept<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31172799\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/31172799\/<\/a><\/td><\/tr><tr><td>31103217<\/td><td width=\"389\">Renal Infarction and Its Consequences for Renal Function in Patients With Cardiac Amyloidosis<\/td><td width=\"391\">Dang J, Abulizi M, Moktefi A, El Karoui K, Deux JF, Bodez D, Le Bras F, Belhadj K, Remy P, Issaurat P, Plante-Bordeneuve V, Molinier-Frenkel V, Fanen P, Guendouz S, Kharoubi M, Itti E, Damy T, Audard V.<\/td><td>Mayo Clin Proc<\/td><td>\u00a02019 Jun<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31103217\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/31103217\/<\/a><\/td><\/tr><tr><td>30938420<\/td><td width=\"389\">Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)<\/td><td width=\"391\">Damy T, Kristen AV, Suhr OB, Maurer MS, Plant\u00e9-Bordeneuve V, Yu CR, Ong ML, Coelho T, Rapezzi C<\/td><td>Radiologie<\/td><td>2021 aout<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30938420\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/30938420\/<\/a><\/td><\/tr><tr><td>30793974<\/td><td width=\"389\">Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations<\/td><td width=\"391\">Concei\u00e7\u00e3o I, Damy T, Romero M, Gal\u00e1n L, Attarian S, Luigetti M, Sadeh M, Sarafov S, Tournev I, Ueda M.<\/td><td>Amyloid<\/td><td>\u00a02019 Mar<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30793974\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/30793974\/<\/a><\/td><\/tr><tr><td>30739754<\/td><td width=\"389\">[Hypertrophic cardiomyopathies]<\/td><td width=\"391\">Lairez O.<\/td><td>Rev Med Interne<\/td><td>\u00a02019 Jun<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30739754\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/30739754\/<\/a><\/td><\/tr><tr><td>30710407<\/td><td width=\"389\">Commentary to \u00ab\u00a0A 44-year-old female with familial Mediterranean fever, cardiomyopathy and end stage renal disease\u00a0\u00bb by Magaki et al<\/td><td width=\"391\">Bodez D, Georgin-Lavialle S, Grateau G, Buob D.<\/td><td>Brain Pathol<\/td><td>\u00a02019 Mar<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30710407\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/30710407\/<\/a><\/td><\/tr><tr><td>30632809<\/td><td width=\"389\">Cause of death analysis and temporal trends in survival after liver transplantation for transthyretin familial amyloid polyneuropathy<\/td><td width=\"391\">Algalarrondo V, Antonini T, Th\u00e9audin M, Chemla D, Benmalek A, Castaing D, Cauquil C, Rouzet F, Mika D, Duong E, Dinanian S, Eliahou L, Le Guludec D, Samuel D, Adams D, Slama MS.<\/td><td>Amyloid<\/td><td>\u00a02018 Dec<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30632809\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/30632809\/<\/a><\/td><\/tr><tr><td>30623354<\/td><td width=\"389\">Left ventricular assessment in patients with systemic light chain amyloidosis: a 3-dimensional speckle tracking transthoracic echocardiographic study<\/td><td width=\"391\">Pradel S, Magne J, Jaccard A, Fadel BM, Boulogne C, Salemi VMC, Damy T, Aboyans V, Mohty D.<\/td><td>Int J Cardiovasc Imaging<\/td><td>\u00a02019 May<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30623354\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/30623354\/<\/a><\/td><\/tr><tr><td>30586695<\/td><td width=\"389\">Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis<\/td><td width=\"391\">Solomon SD, Adams D, Kristen A, Grogan M, Gonz\u00e1lez-Duarte A, Maurer MS, Merlini G, Damy T, Slama MS, Brannagan TH 3rd, Dispenzieri A, Berk JL, Shah AM, Garg P, Vaishnaw A, Karsten V, Chen J, Gollob J, Vest J, Suhr O.<\/td><td>Circulation<\/td><td>\u00a02019 Jan 22<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30586695\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/30586695\/<\/a><\/td><\/tr><tr><td>30145929<\/td><td width=\"389\">Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy<\/td><td width=\"391\">Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C<\/td><td>N Engl J Med<\/td><td>2018 Sept<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30145929\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/30145929\/<\/a><\/td><\/tr><tr><td>30122209<\/td><td width=\"389\">Author&rsquo;s reply<\/td><td width=\"391\">Mohty D, Petitalot V, Magne J, Fadel BM, Boulogne C, Rouabhia D, El Hamel C, Lavergne D, Damy T, Aboyans V, Jaccard A.<\/td><td>J Cardiol<\/td><td>\u00a02018 Oct<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30122209\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/30122209\/<\/a><\/td><\/tr><tr><td>30115079<\/td><td width=\"389\">Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis<\/td><td width=\"391\">Ridouani F, Damy T, Tacher V, Derbel H, Legou F, Sifaoui I, Audureau E, Bodez D, Rahmouni A, Deux JF.<\/td><td>J Cardiovasc Magn Reson<\/td><td>\u00a02018 Aug 16<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30115079\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/30115079\/<\/a><\/td><\/tr><tr><td>30072291<\/td><td width=\"389\">Quantification of Myocardial Enhancement on Cine-MRI: Diagnostic Value in Cardiac Amyloidosis<\/td><td width=\"391\">Cholet C, Damy T, Legou F, Kobeiter H, Rahmouni A, Deux JF.<\/td><td>Acad Radiol<\/td><td>\u00a02019 Jun<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30072291\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/30072291\/<\/a><\/td><\/tr><tr><td>30030912<\/td><td width=\"389\">Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues<\/td><td width=\"391\">Berthelot E, Bauer F, Eicher JC, Fl\u00e9cher E, Gellen B, Guihaire J, Guijarro D, Roul G, Salvat M, Tribouilloy C, Zores F, Lamblin N, de Groote P, Damy T.<\/td><td>ESC Heart Fail<\/td><td>\u00a02018 Oct<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30030912\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/30030912\/<\/a><\/td><\/tr><tr><td>29881913<\/td><td width=\"389\">Pattern of myocardial (99m)Tc-HMDP uptake and impact on myocardial function in patients with transthyretin cardiac amyloidosis<\/td><td width=\"391\">Pradel S, Brun S, Victor G, Pascal P, Fournier P, Ribes D, Lavie-Badie Y, Galinier M, Carri\u00e9 D, Berry I, Lairez O<\/td><td>\u00a0<\/td><td>\u00a0<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29881913\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/29881913\/<\/a><\/td><\/tr><tr><td>29709420<\/td><td width=\"389\">Outcome of patients with cardiac amyloidosis admitted to an intensive care unit for acute heart failure<\/td><td width=\"391\">d&rsquo;Humi\u00e8res T, Fard D, Damy T, Roubille F, Galat A, Doan HL, Oliver L, Dubois-Rand\u00e9 JL, Squara P, Lim P, Ternacle J.<\/td><td>Arch Cardiovasc Dis<\/td><td>\u00a02018 Oct<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29709420\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/29709420\/<\/a><\/td><\/tr><tr><td>29574587<\/td><td width=\"389\">Can Nuclear Imaging Techniques Predict Patient Outcome and Guide Medical Management in Hereditary Transthyretin Cardiac Amyloidosis?<\/td><td width=\"391\">Algalarrondo V, Piekarski E, Eliahou L, Le Guludec D, Slama MS, Rouzet F.<\/td><td>Curr Cardiol Rep<\/td><td>\u00a02018 Mar 24<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29574587\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/29574587\/<\/a><\/td><\/tr><tr><td>29511839<\/td><td width=\"389\">Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers<\/td><td width=\"391\">Piekarski E, Chequer R, Algalarrondo V, Eliahou L, Mahida B, Vigne J, Adams D, Slama MS, Le Guludec D, Rouzet F.<\/td><td>Eur J Nucl Med Mol Imaging<\/td><td>2018 Jul<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29511839\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/29511839\/<\/a><\/td><\/tr><tr><td>29260587<\/td><td width=\"389\">Right ventricular longitudinal strain: a tool for diagnosis and prognosis in light-chain amyloidosis<\/td><td width=\"391\">Uzan C, Lairez O, Raud-Raynier P, Garcia R, Degand B, Christiaens LP, Rehman MB.<\/td><td>Amyloid<\/td><td>\u00a02018 Mar<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29260587\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/29260587\/<\/a><\/td><\/tr><tr><td>29153741<\/td><td width=\"389\">Left atrial function in patients with light chain amyloidosis: A transthoracic 3D speckle tracking imaging study<\/td><td width=\"391\">Mohty D, Petitalot V, Magne J, Fadel BM, Boulogne C, Rouabhia D, El Hamel C, Lavergne D, Damy T, Aboyans V, Jaccard A.<\/td><td>J Cardiol<\/td><td>\u00a02018 Apr<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29153741\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/29153741\/<\/a><\/td><\/tr><tr><td>29048471<\/td><td width=\"389\">A new staging system for cardiac transthyretin amyloidosis<\/td><td width=\"391\">Gillmore JD, Damy T, Fontana M, Hutchinson M, Lachmann HJ, Martinez-Naharro A, Quarta CC, Rezk T, Whelan CJ, Gonzalez-Lopez E, Lane T, Gilbertson JA, Rowczenio D, Petrie A, Hawkins PN.<\/td><td>Eur Heart J<\/td><td>\u00a02018 Aug 7<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29048471\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/29048471\/<\/a><\/td><\/tr><tr><td>28812126<\/td><td width=\"389\">Myocardial iodine concentration measurement using dual-energy computed tomography for the diagnosis of cardiac amyloidosis: a pilot study<\/td><td width=\"391\">Chevance V, Damy T, Tacher V, Legou F, Ridouani F, Luciani A, Kobeiter H, Rahmouni A, Deux JF.<\/td><td>Eur Radiol<\/td><td>\u00a02018 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28812126\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/28812126\/<\/a><\/td><\/tr><tr><td>28598686<\/td><td width=\"389\">How your ears can tell what is hidden in your heart: wild-type transthyretin amyloidosis as potential cause of sensorineural hearing loss inelderly-AmyloDEAFNESS pilot study<\/td><td width=\"391\">B\u00e9quignon E, Guellich A, Bartier S, Raynal M, Pruli\u00e8re-Escabasse V, Canou\u00ef-Poitrine F, Coste A, Damy T.<\/td><td>Amyloid<\/td><td>\u00a02017 Jun<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28598686\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/28598686\/<\/a><\/td><\/tr><tr><td>28553897<\/td><td width=\"389\">Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosis<\/td><td width=\"391\">Cariou E, Bennani Smires Y, Victor G, Robin G, Ribes D, Pascal P, Petermann A, Fournier P, Faguer S, Roncalli J, Rousseau H, Chauveau D, Carri\u00e9 D, Berry I, Galinier M, Lairez O<\/td><td>Amyloid<\/td><td>2017 juin<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28553897\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/28553897\/<\/a><\/td><\/tr><tr><td>28447284<\/td><td width=\"389\">Apical sparing pattern of left ventricular myocardial (99m)Tc-HMDP uptake in patients with transthyretin cardiac amyloidosis<\/td><td width=\"391\">Van Der Gucht A, Cottereau AS, Abulizi M, Guellich A, Blanc-Durand P, Israel JM, Galat A, Plante-Bordeneuve V, Dubois-Rand\u00e9 JL, Bodez D, Rosso J, Damy T, Itti E.<\/td><td>J Nucl Cardiol<\/td><td>\u00a02018 Dec<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28447284\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/28447284\/<\/a><\/td><\/tr><tr><td>28384285<\/td><td width=\"389\">Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis &#8211; Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)<\/td><td width=\"391\">Kristen AV, Maurer MS, Rapezzi C, Mundayat R, Suhr OB, Damy T<\/td><td>Plos One<\/td><td>2017 Avril<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28384285\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/28384285\/<\/a><\/td><\/tr><tr><td>28334621<\/td><td width=\"389\">Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosis<\/td><td width=\"391\">Le Bras F, Molinier-Frenkel V, Guellich A, Dupuis J, Belhadj K, Guendouz S, Ayad K, Colombat M, Benhaiem N, Tissot CM, Hulin A, Jaccard A, Damy T.<\/td><td>Eur J Cancer<\/td><td>\u00a02017 May<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28334621\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/28334621\/<\/a><\/td><\/tr><tr><td>28219562<\/td><td width=\"389\">Isolated Pericardial Infiltration Without Myocardial Involvement in\u00a0Light-Chain-Related Amyloidosis<\/td><td width=\"391\">Georgin-Lavialle S, Guellich A, Deux JF, Buob D, Damy T.<\/td><td>Ann Thorac Surg<\/td><td>\u00a02017 Mar<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28219562\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/28219562\/<\/a><\/td><\/tr><tr><td>28082242<\/td><td width=\"389\">New guidelines, new recommendations! But what is really new? A pragmatic interpretation of the 2016 European guidelines for the management of chronic heart failure<\/td><td width=\"391\">de Groote P, Cohen A, Juilli\u00e8re Y, Damy T.<\/td><td>Arch Cardiovasc Dis<\/td><td>\u00a02017 Jan<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28082242\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/28082242\/<\/a><\/td><\/tr><tr><td>27933393<\/td><td width=\"389\">Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis<\/td><td width=\"391\">Mohty D, Pradel S, Magne J, Fadel B, Boulogne C, Petitalot V, Raboukhi S, Darodes N, Damy T, Aboyans V, Jaccard A.<\/td><td>Clin Res Cardiol<\/td><td>\u00a02017 May<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27933393\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27933393\/<\/a><\/td><\/tr><tr><td>27878441<\/td><td width=\"389\">Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study<\/td><td width=\"391\">Plant\u00e9-Bordeneuve V, Gorram F, Salhi H, Nordine T, Ayache SS, Le Corvoisier P, Azoulay D, Feray C, Damy T, Lefaucheur JP.<\/td><td>J Neurol<\/td><td>\u00a02017 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27878441\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27878441\/<\/a><\/td><\/tr><tr><td>27838303<\/td><td width=\"389\">Cardiac Dysautonomia Predicts Long-Term Survival in Hereditary Transthyretin Amyloidosis After Liver\u00a0Transplantation<\/td><td width=\"391\">Algalarrondo V, Antonini T, Th\u00e9audin M, Chemla D, Benmalek A, Lacroix C, Castaing D, Cauquil C, Dinanian S, Eliahou L, Samuel D, Adams D, Le Guludec D, Slama MS, Rouzet F.<\/td><td>JACC Cardiovasc Imaging<\/td><td>\u00a02016 Dec<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27838303\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27838303\/<\/a><\/td><\/tr><tr><td>27836786<\/td><td width=\"389\">Non-vitamin K antagonist oral anticoagulants and heart failure<\/td><td width=\"391\">Isnard R, Bauer F, Cohen-Solal A, Damy T, Donal E, Galinier M, Hag\u00e8ge A, Jourdain P, Leclercq C, Sabatier R, Trochu JN, Cohen A.<\/td><td>Arch Cardiovasc Dis<\/td><td>\u00a02016 Nov<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27836786\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27836786\/<\/a><\/td><\/tr><tr><td>27804073<\/td><td width=\"389\">Early-phase myocardial uptake intensity of (99m)Tc-HMDP vs (99m)Tc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis<\/td><td width=\"391\">Abulizi M, Cottereau AS, Guellich A, Vandeventer S, Galat A, Van Der Gucht A, Plante-Bordeneuve V, Dubois-Rand\u00e9 JL, Bodez D, Rosso J, Damy T, Itti E.<\/td><td>J Nucl Cardiol<\/td><td>\u00a02018 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27804073\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27804073\/<\/a><\/td><\/tr><tr><td>27798053<\/td><td width=\"389\">Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy<\/td><td width=\"391\">Rosmini S, Biagini E, O&rsquo;Mahony C, Bulluck H, Ruozi N, Lopes LR, Guttmann O, Reant P, Quarta CC, Pantazis A, Tome-Esteban M, Mckenna WJ, Rapezzi C, Elliott PM.<\/td><td>Heart<\/td><td>\u00a02017 Feb 15<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27798053\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27798053\/<\/a><\/td><\/tr><tr><td>27692958<\/td><td width=\"389\">Usefulness of T2 ratio in the diagnosis and prognosis of cardiac amyloidosis using cardiac MR imaging<\/td><td width=\"391\">Legou F, Tacher V, Damy T, Plant\u00e9-Bordeneuve V, Rappeneau S, Benhaiem N, Rosso J, Itti E, Luciani A, Kobeiter H, Rahmouni A, Deux JF.<\/td><td>Diagn Interv Imaging<\/td><td>\u00a02017 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27692958\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27692958\/<\/a><\/td><\/tr><tr><td>27647161<\/td><td width=\"389\">Identification of prognostic markers in transthyretin and AL cardiac amyloidosis<\/td><td width=\"391\">Damy T, Jaccard A, Guellich A, Lavergne D, Galat A, Deux JF, Hittinger L, Dupuis J, Frenkel V, Rigaud C, Plante-Bordeneuve V, Bodez D, Mohty D.<\/td><td>Amyloid<\/td><td>\u00a02016 Sep<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27647161\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27647161\/<\/a><\/td><\/tr><tr><td>27513652<\/td><td width=\"389\">Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis<\/td><td width=\"391\">Hamon D, Algalarrondo V, Gandjbakhch E, Extramiana F, Marijon E, Elbaz N, Selhane D, Dubois-Rande JL, Teiger E, Plante-Bordeneuve V, Damy T, Lellouche N.<\/td><td>Int J Cardiol<\/td><td>\u00a02016 Nov 1<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27513652\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27513652\/<\/a><\/td><\/tr><tr><td>27492996<\/td><td width=\"389\">Cardiac amyloidosis: How to recognize them and manage them?<\/td><td width=\"391\">Bodez D, Galat A, Guellich A, Deux JF, Rosso J, Le Bras F, Funalot B, Fanen P, Benhaiem N, Plant\u00e9-Bordeneuve V, Dubois-Rand\u00e9 JL, Lellouche N, Guendouz S, Molinier-Frenkel V, Mohty D, Damy T.<\/td><td>Presse Med<\/td><td>\u00a02016 Oct<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27492996\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27492996\/<\/a><\/td><\/tr><tr><td>27424245<\/td><td width=\"389\">Early Phase (99)Tc-HMDP Scintigraphy for the Diagnosis and Typing of Cardiac Amyloidosis<\/td><td width=\"391\">Galat A, Van der Gucht A, Guellich A, Bodez D, Cottereau AS, Guendouz S, Hittinger L, Dubois-Rand\u00e9 JL, Plante-Bordeneuve V, Itti E, Meignan M, Damy T, Rosso J.<\/td><td>JACC Cardiovasc Imaging<\/td><td>\u00a02017 May<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27424245\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27424245\/<\/a><\/td><\/tr><tr><td>27386769<\/td><td width=\"389\">Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)<\/td><td width=\"391\">Maurer MS, Hanna M, Grogan M, Dispenzieri A, Witteles R, Drachman B, Judge DP, Lenihan DJ, Gottlieb SS, Shah SJ, Steidley DE, Ventura H, Murali S, Silver MA, Jacoby D, Fedson S, Hummel SL, Kristen AV, Damy T, Plant\u00e9-Bordeneuve V, Coelho T, Mundayat R, Suhr OB, Waddington Cruz M, Rapezzi C<\/td><td>J Am Coll Cardiol<\/td><td>2016 Jul<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27386769\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27386769\/<\/a><\/td><\/tr><tr><td>27371713<\/td><td width=\"389\">One train may hide another: look beyond the aortic valve for cardiac amyloidosis<\/td><td width=\"391\">Venner C, Busby-Venner H, Selton-Suty C, Huttin O.<\/td><td>Eur Heart J<\/td><td>\u00a02016 Dec 14<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27371713\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27371713\/<\/a><\/td><\/tr><tr><td>27348696<\/td><td width=\"389\">Prognostic value of right ventricular systolic function in cardiac amyloidosis<\/td><td width=\"391\">Bodez D, Ternacle J, Guellich A, Galat A, Lim P, Radu C, Guendouz S, Bergoend E, Couetil JP, Hittinger L, Dubois-Rand\u00e9 JL, Plante-Bordeneuve V, Deux JF, Mohty D, Damy T.<\/td><td>Amyloid<\/td><td>\u00a02016 Sep<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27348696\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27348696\/<\/a><\/td><\/tr><tr><td>27240600<\/td><td width=\"389\">Pilot study for left ventricular imaging phenotype of patients over 65\u00a0years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy<\/td><td width=\"391\">Bennani Smires Y, Victor G, Ribes D, Berry M, Cognet T, M\u00e9jean S, Huart A, Roussel M, Petermann A, Roncalli J, Carri\u00e9 D, Rousseau H, Berry I, Chauveau D, Galinier M, Lairez O.<\/td><td>Int J Cardiovasc Imaging<\/td><td>\u00a02016 Sep<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27240600\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27240600\/<\/a><\/td><\/tr><tr><td>27194782<\/td><td width=\"389\">Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study<\/td><td width=\"391\">Mohty D, Boulogne C, Magne J, Varroud-Vial N, Martin S, Ettaif H, Fadel BM, Bridoux F, Aboyans V, Damy T, Jaccard A.<\/td><td>Eur Heart J Cardiovasc Imaging<\/td><td>\u00a02016 Sep<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27194782\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27194782\/<\/a><\/td><\/tr><tr><td>27143678<\/td><td width=\"389\">Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis<\/td><td width=\"391\">Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN.<\/td><td>Circulation<\/td><td>\u00a02016 Jun 14<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27143678\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27143678\/<\/a><\/td><\/tr><tr><td>27091529<\/td><td width=\"389\">Prevalence, Severity, and Prognostic Value of Sleep Apnea Syndromes in Cardiac Amyloidosis<\/td><td width=\"391\">Bodez D, Guellich A, Kharoubi M, Covali-Noroc A, Tissot CM, Guendouz S, Hittinger L, Dubois-Rand\u00e9 JL, Lefaucheur JP, Plant\u00e9-Bordeneuve V, Adnot S, Boyer L, Damy T.<\/td><td>Sleep<\/td><td>\u00a02016 Jul 1<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27091529\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27091529\/<\/a><\/td><\/tr><tr><td>27002091<\/td><td width=\"389\">Response to Letters Regarding Article, \u00ab\u00a0Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis\u00a0\u00bb<\/td><td width=\"391\">Fontana M, Pica S, Reant P, Abdel-Gadir A, Treibel TA, Banypersad SM, Maestrini V, Barcella W, Rosmini S, Bulluck H, Sayed RH, Patel K, Mamhood S, Bucciarelli-Ducci C, Whelan CJ, Herrey AS, Lachmann HJ, Wechalekar AD, Manisty CH, Schelbert EB, Kellman P, Gillmore JD, Hawkins PN, Moon JC.<\/td><td>Circulation<\/td><td>\u00a02016 Mar 22<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27002091\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/27002091\/<\/a><\/td><\/tr><tr><td>26908951<\/td><td width=\"389\">Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?<\/td><td width=\"391\">Galat A, Guellich A, Bodez D, Slama M, Dijos M, Zeitoun DM, Milleron O, Attias D, Dubois-Rand\u00e9 JL, Mohty D, Audureau E, Teiger E, Rosso J, Monin JL, Damy T.<\/td><td>Eur Heart J<\/td><td>\u00a02016 Dec 14<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26908951\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/26908951\/<\/a><\/td><\/tr><tr><td>26880259<\/td><td width=\"389\">Multimodality Imaging of Cardiac Transthyretin Amyloidosis 16 Years After a Domino Liver Transplantation<\/td><td width=\"391\">Bechiri MY, Eliahou L, Rouzet F, Fouret PJ, Antonini T, Samuel D, Adam R, Adams D, Slama MS, Algalarrondo V.<\/td><td>Am J Transplant<\/td><td>\u00a02016 Jul<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26880259\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/26880259\/<\/a><\/td><\/tr><tr><td>26870387<\/td><td width=\"389\">Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy<\/td><td width=\"391\">Damy T, Maurer MS, Rapezzi C, Plant\u00e9-Bordeneuve V, Karayal ON, Mundayat R, Suhr OB, Kristen AV.<\/td><td>Open Heart<\/td><td>\u00a02016 Feb 8<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26870387\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/26870387\/<\/a><\/td><\/tr><tr><td>26825321<\/td><td width=\"389\">Cardiac amyloidosis: an unusual cause of low flow-low gradient aortic stenosis with preserved ejection fraction<\/td><td width=\"391\">Haloui F, Salaun E, Maysou L, Dehaene A, Habib G.<\/td><td>Eur Heart J Cardiovasc Imaging<\/td><td>2016 Apr<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26825321\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/26825321\/<\/a><\/td><\/tr><tr><td>26777222<\/td><td width=\"389\">Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis<\/td><td width=\"391\">Ternacle J, Bodez D, Guellich A, Audureau E, Rappeneau S, Lim P, Radu C, Guendouz S, Couetil JP, Benhaiem N, Hittinger L, Dubois-Rand\u00e9 JL, Plante-Bordeneuve V, Mohty D, Deux JF, Damy T.<\/td><td>JACC Cardiovasc Imaging<\/td><td>\u00a02016 Feb<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26777222\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/26777222\/<\/a><\/td><\/tr><tr><td>26537620<\/td><td width=\"389\">Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness<\/td><td width=\"391\">Damy T, Costes B, Hag\u00e8ge AA, Donal E, Eicher JC, Slama M, Guellich A, Rappeneau S, Gueffet JP, Logeart D, Plant\u00e9-Bordeneuve V, Bouvaist H, Huttin O, Mulak G, Dubois-Rand\u00e9 JL, Goossens M, Canoui-Poitrine F, Buxbaum JN.<\/td><td>Eur Heart J<\/td><td>\u00a02016 Jun 14<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26537620\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/26537620\/<\/a><\/td><\/tr><tr><td>26516176<\/td><td width=\"389\">Haematological determinants of cardiac involvement in adults with sickle cell disease<\/td><td width=\"391\">Damy T, Bodez D, Habibi A, Guellich A, Rappeneau S, Inamo J, Guendouz S, Gellen-Dautremer J, Pissard S, Loric S, Wagner-Ballon O, Godeau B, Adnot S, Dubois-Rand\u00e9 JL, Hittinger L, Galact\u00e9ros F, Bartolucci P.<\/td><td>Eur Heart J<\/td><td>\u00a02016 Apr 7<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26516176\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/26516176\/<\/a><\/td><\/tr><tr><td>26465835<\/td><td width=\"389\">Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis<\/td><td width=\"391\">Galat A, Rosso J, Guellich A, Van Der Gucht A, Rappeneau S, Bodez D, Guendouz S, Tissot CM, Hittinger L, Dubois-Rand\u00e9 JL, Plante-Bordeneuve V, Itti E, Meignan M, Damy T.<\/td><td>Amyloid<\/td><td>2015<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26465835\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/26465835\/<\/a><\/td><\/tr><tr><td>26403145<\/td><td width=\"389\">[18F]-NaF PET\/CT imaging in cardiac amyloidosis<\/td><td width=\"391\">Van Der Gucht A, Galat A, Rosso J, Guellich A, Garot J, Bodez D, Plante-Bordeneuve V, Hittinger L, Dubois-Rand\u00e9 JL, Evangelista E, Sasanelli M, Chalaye J, Meignan M, Itti E, Damy T.<\/td><td>J Nucl Cardiol<\/td><td>\u00a02016 Aug<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26403145\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/26403145\/<\/a><\/td><\/tr><tr><td>26362631<\/td><td width=\"389\">Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis<\/td><td width=\"391\">Fontana M, Pica S, Reant P, Abdel-Gadir A, Treibel TA, Banypersad SM, Maestrini V, Barcella W, Rosmini S, Bulluck H, Sayed RH, Patel K, Mamhood S, Bucciarelli-Ducci C, Whelan CJ, Herrey AS, Lachmann HJ, Wechalekar AD, Manisty CH, Schelbert EB, Kellman P, Gillmore JD, Hawkins PN, Moon JC.<\/td><td>Circulation<\/td><td>\u00a02015 Oct 20<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26362631\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/26362631\/<\/a><\/td><\/tr><tr><td>26002815<\/td><td width=\"389\">(99m)Tc-HMDP scintigraphy rectifies wrong diagnosis of AL amyloidosis<\/td><td width=\"391\">Galat A, Van Der Gucht A, Colombat M, Attias D, Itti E, Meignan M, Lebras F, Molinier-Frenkel V, Benhaiem N, Guellich A, Rosso J, Damy T.<\/td><td>J Nucl Cardiol<\/td><td>\u00a02015 Aug<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26002815\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/26002815\/<\/a><\/td><\/tr><tr><td>25743445<\/td><td width=\"389\">Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis<\/td><td width=\"391\">Damy T, Judge DP, Kristen AV, Berthet K, Li H, Aarts J.<\/td><td>J Cardiovasc Transl Res<\/td><td>\u00a02015 Mar<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25743445\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/25743445\/<\/a><\/td><\/tr><tr><td>25693664<\/td><td width=\"389\">Noninvasive detection of cardiac amyloidosis using delayed enhanced MDCT: a pilot study<\/td><td width=\"391\">Deux JF, Mihalache CI, Legou F, Damy T, Mayer J, Rappeneau S, Plant\u00e9-Bordeneuve V, Luciani A, Kobeiter H, Rahmouni A.<\/td><td>Eur Radiol<\/td><td>\u00a02015 Aug<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25693664\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/25693664\/<\/a><\/td><\/tr><tr><td>25416603<\/td><td width=\"389\">Current and future treatment of amyloid neuropathies<\/td><td width=\"391\">Adams D, Cauquil C, Theaudin M, Rousseau A, Algalarrondo V, Slama MS.<\/td><td>Expert Rev Neurother<\/td><td>\u00a02014 Dec<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25416603\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/25416603\/<\/a><\/td><\/tr><tr><td>25211144<\/td><td width=\"389\">Noninvasive detection of cardiac involvement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance imaging: a prospective study<\/td><td width=\"391\">Deux JF, Damy T, Rahmouni A, Mayer J, Plant\u00e9-Bordeneuve V.<\/td><td>Amyloid<\/td><td>\u00a02014 Dec<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25211144\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/25211144\/<\/a><\/td><\/tr><tr><td>25069833<\/td><td width=\"389\">Familial amyloid polyneuropathy: elaboration of a therapeutic patient education programme, \u00ab\u00a0EdAmyl\u00a0\u00bb<\/td><td width=\"391\">Th\u00e9audin M, Cauquil C, Antonini T, Algalarrondo V, Labeyrie C, Aycaguer S, Cl\u00e9ment M, Kubezyk M, Nonnez G, Morier A, Bourges C, Darras A, Mouzat L, Adams D.<\/td><td>Amyloid<\/td><td>\u00a02014 Dec<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25069833\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/25069833\/<\/a><\/td><\/tr><tr><td>24997877<\/td><td width=\"389\">Answer to the letter from Mrs Aur\u00e9lie Daumas about our article \u00ab\u00a0senile systemic amyloidosis: definition, diagnosis, why thinking about?\u00a0\u00bb<\/td><td width=\"391\">Rosso J, Gallat A, Guellich A, Damy T<\/td><td>Presse Med<\/td><td>2014 Sept<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24997877\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/24997877\/<\/a><\/td><\/tr><tr><td>24482069<\/td><td width=\"389\">FAP neuropathy and emerging treatments<\/td><td width=\"391\">Adams D, Th\u00e9audin M, Cauquil C, Algalarrondo V, Slama M.<\/td><td>Curr Neurol Neurosci Rep<\/td><td>\u00a02014 Mar<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24482069\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/24482069\/<\/a><\/td><\/tr><tr><td>24090573<\/td><td width=\"389\">Cardiac amyloidosis: a case series of 14 patients, description and prognosis<\/td><td width=\"391\">Isabel C, Georgin-Lavialle S, Aouba A, Delarue R, Nochy D, Karras A, Azarine A, Hermine O, Ranque B, Hag\u00e8ge A, Pouchot J.<\/td><td>Rev Med Interne<\/td><td>\u00a02013 Nov<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24090573\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/24090573\/<\/a><\/td><\/tr><tr><td>24070600<\/td><td width=\"389\">Cardiac amyloidosis: updates in diagnosis and management<\/td><td width=\"391\">Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, Jaccard A.<\/td><td>Arch Cardiovasc Dis<\/td><td>\u00a02013 Oct<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24070600\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/24070600\/<\/a><\/td><\/tr><tr><td>24070596<\/td><td width=\"389\">Characterization of untyped cardiac amyloidosis by mass spectrometry in a patient with Gly6Ser transthyretin polymorphism in fatal cardiogenic shock<\/td><td width=\"391\">Damy T, Plante-Bordeneuve V, Dogan A.<\/td><td>Arch Cardiovasc Dis<\/td><td>\u00a02014 Dec<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24070596\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/24070596\/<\/a><\/td><\/tr><tr><td>23964755<\/td><td width=\"389\">Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis<\/td><td width=\"391\">Damy T, Deux JF, Moutereau S, Guendouz S, Mohty D, Rappeneau S, Guellich A, Hittinger L, Loric S, Lefaucheur JP, Plante-Bordeneuve V.<\/td><td>Amyloid<\/td><td>\u00a02013 Dec<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23964755\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/23964755\/<\/a><\/td><\/tr><tr><td>23669316<\/td><td width=\"389\">[Senile systemic amyloidosis: definition, diagnosis, why thinking about?]<\/td><td width=\"391\">Damy T, Mohty D, Deux JF, Rosso J, Benhaiem N, Lellouche N, Sabbah L, Guendouz S, Tissot CM, Rappeneau S, Pongas D, Bodez D, Krypciak S, Guellich A, Dubois-Rand\u00e9 JL, Hittinger L, Lefaucheur JP, Jaccard A, Plant\u00e9-Bordeneuve V.<\/td><td>Presse Med<\/td><td>\u00a02013 Jun<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23669316\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/23669316\/<\/a><\/td><\/tr><tr><td>23306657<\/td><td width=\"389\">Neurophysiological markers of small fibre neuropathy in TTR-FAP mutation carriers<\/td><td width=\"391\">Lefaucheur JP, Ng Wing Tin S, Kerschen P, Damy T, Plant\u00e9-Bordeneuve V.<\/td><td>J Neurol<\/td><td>\u00a02013 Jun<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23306657\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/23306657\/<\/a><\/td><\/tr><tr><td>23177490<\/td><td width=\"389\">Diagnosis of cardiac amyloidosis by magnetic resonance imaging due to a new mutation in the transthyretin gene<\/td><td width=\"391\">Damy T, Plante-Bordeneuve V, Valleix S.<\/td><td>Arch Cardiovasc Dis<\/td><td>\u00a02012 Nov<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23177490\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/23177490\/<\/a><\/td><\/tr><tr><td>22709469<\/td><td width=\"389\">Circadian rhythm of blood pressure reflects the severity of cardiac impairment in familial amyloid polyneuropathy<\/td><td width=\"391\">Algalarrondo V, Eliahou L, Thierry I, Bouzeman A, Dasoveanu M, Sebag C, Moubarak G, Le Guludec D, Samuel D, Adams D, Dinanian S, Slama MS.<\/td><td>Arch Cardiovasc Dis<\/td><td>\u00a02012 May<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22709469\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/22709469\/<\/a><\/td><\/tr><tr><td>22387306<\/td><td width=\"389\">Prophylactic pacemaker implantation in familial amyloid polyneuropathy<\/td><td width=\"391\">Algalarrondo V, Dinanian S, Juin C, Chemla D, Bennani SL, Sebag C, Plant\u00e9 V, Le Guludec D, Samuel D, Adams D, Slama MS.<\/td><td>Heart Rhythm<\/td><td>\u00a02012 Jul<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22387306\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/22387306\/<\/a><\/td><\/tr><tr><td>20800158<\/td><td width=\"389\">Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging<\/td><td width=\"391\">Mekinian A, Lions C, Leleu X, Duhamel A, Lamblin N, Coiteux V, De Groote P, Hatron PY, Facon T, Beregi JP, Hachulla E, Launay D<\/td><td>Am J Med<\/td><td>2010 Sept<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20800158\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/20800158\/<\/a><\/td><\/tr><tr><td>20142122<\/td><td width=\"389\">Left ventricular hypertrophy: cardiac magnetic resonance may help differentiate amyloidosis from hypertrophic cardiomyopathy<\/td><td width=\"391\">Mabru M, Dacher JN, Bauer F.<\/td><td>Arch Cardiovasc Dis<\/td><td>\u00a02010 Jan<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20142122\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/20142122\/<\/a><\/td><\/tr><tr><td>18579503<\/td><td width=\"389\">Mitochondriopathy: a rare aetiology of restrictive cardiomyopathy<\/td><td width=\"391\">Thebault C, Ollivier R, Leurent G, Marcorelles P, Langella B, Donal E.<\/td><td>Eur J Echocardiogr<\/td><td>\u00a02008 Nov<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18579503\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/18579503\/<\/a><\/td><\/tr><tr><td>16797793<\/td><td width=\"389\">Original case report of amyloidosis with pleural involvement: the role of echocardiography in the diagnosis<\/td><td width=\"391\">Roubille F, Billotet C, Roubille C.<\/td><td>Rev Med Interne<\/td><td>\u00a02006 Oct<\/td><td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16797793\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/16797793\/<\/a><\/td><\/tr><\/tbody><\/table>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-9ff1dc3 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"9ff1dc3\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-ecdec8a\" data-id=\"ecdec8a\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-b4b8723 elementor-widget elementor-widget-text-editor\" data-id=\"b4b8723\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h6><span style=\"color: #000000\">Nos experts pr\u00e9sentent les articles de l&rsquo;actualit\u00e9 de mani\u00e8re interactive dans la Bibli&rsquo;OSE : la bibliographie de l&rsquo;amylose.\u00a0<\/span><\/h6><h6><span style=\"color: #000000\">Vous pouvez assister aux live. Un jeudi sur deux de 13h30 \u00e0 14h00 :<\/span> <a href=\"http:\/\/www.bibliose.org\/\" target=\"_blank\" rel=\"noopener\">www.bibliose.org<\/a><\/h6><h6><span style=\"color: #000000\">Les replays de ces \u00e9missions sont \u00e9galement disponibles sur cette m\u00eame plateforme et sur notre chaine YouTube <a href=\"https:\/\/www.youtube.com\/watch?v=ODEjbmQwU_g&amp;list=PLgcbJqP0xnzi_t6pS5Pm5N_TsA9x7EJ0-&amp;ab_channel=R%C3%A9seauAmylose\" target=\"_blank\" rel=\"noopener\">CLIQUEZ ICI.<\/a><\/span><\/h6>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-81b53b5\" data-id=\"81b53b5\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6678c62 elementor-cta--skin-cover elementor-animated-content elementor-bg-transform elementor-bg-transform-zoom-in elementor-widget elementor-widget-call-to-action\" data-id=\"6678c62\" data-element_type=\"widget\" data-widget_type=\"call-to-action.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<a class=\"elementor-cta\" href=\"http:\/\/www.bibliose.org\/\" target=\"_blank\">\n\t\t\t\t\t<div class=\"elementor-cta__bg-wrapper\">\n\t\t\t\t<div class=\"elementor-cta__bg elementor-bg\" style=\"background-image: url(https:\/\/reseau-amylose.org\/rechercheamylose\/wp-content\/uploads\/sites\/3\/2022\/07\/Capture-de\u0301cran-2022-07-18-a\u0300-14.48.51.png);\" role=\"img\" aria-label=\"Capture d\u2019e\u0301cran 2022-07-18 a\u0300 14.48.51\"><\/div>\n\t\t\t\t<div class=\"elementor-cta__bg-overlay\"><\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-cta__content\">\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-cta__button-wrapper elementor-cta__content-item elementor-content-item elementor-animated-item--grow\">\n\t\t\t\t\t<span class=\"elementor-cta__button elementor-button elementor-size-md\">\n\t\t\t\t\t\tCliquez ici\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Articles publi\u00e9s par les experts du R\u00e9seau Amylose Consultez les articles publi\u00e9s par les experts du R\u00e9seau Amylose. le num\u00e9ro PMID vous permet de retrouver l&rsquo;article et le lien pubmed de le consulter en ligne. Pour retrouver un article dans ce tableau, s\u00e9lectionnez sur votre clavier \u00ab\u00a0ctrl + F\u00a0\u00bb et tapez des mots cl\u00e9s de [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-3440","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Publications - R\u00e9seau Amylose Recherche<\/title>\n<meta name=\"description\" content=\"Consultez les articles publi\u00e9s par les experts du R\u00e9seau Amylose - publications - centres experts - amyloses cardiaques\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/reseau-amylose.org\/rechercheamylose\/publications\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Publications - R\u00e9seau Amylose Recherche\" \/>\n<meta property=\"og:description\" content=\"Consultez les articles publi\u00e9s par les experts du R\u00e9seau Amylose - publications - centres experts - amyloses cardiaques\" \/>\n<meta property=\"og:url\" content=\"http:\/\/reseau-amylose.org\/rechercheamylose\/publications\/\" \/>\n<meta property=\"og:site_name\" content=\"R\u00e9seau Amylose Recherche\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-18T12:52:33+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"39 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/reseau-amylose.org\/rechercheamylose\/publications\/\",\"url\":\"http:\/\/reseau-amylose.org\/rechercheamylose\/publications\/\",\"name\":\"Publications - R\u00e9seau Amylose Recherche\",\"isPartOf\":{\"@id\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/#website\"},\"datePublished\":\"2022-07-13T12:11:59+00:00\",\"dateModified\":\"2022-07-18T12:52:33+00:00\",\"description\":\"Consultez les articles publi\u00e9s par les experts du R\u00e9seau Amylose - publications - centres experts - amyloses cardiaques\",\"breadcrumb\":{\"@id\":\"http:\/\/reseau-amylose.org\/rechercheamylose\/publications\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/reseau-amylose.org\/rechercheamylose\/publications\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/reseau-amylose.org\/rechercheamylose\/publications\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publications\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/#website\",\"url\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/\",\"name\":\"R\u00e9seau Amylose Recherche\",\"description\":\"Centre de r\u00e9f\u00e9rence des amyloses cardiaques\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Publications - R\u00e9seau Amylose Recherche","description":"Consultez les articles publi\u00e9s par les experts du R\u00e9seau Amylose - publications - centres experts - amyloses cardiaques","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/reseau-amylose.org\/rechercheamylose\/publications\/","og_locale":"fr_FR","og_type":"article","og_title":"Publications - R\u00e9seau Amylose Recherche","og_description":"Consultez les articles publi\u00e9s par les experts du R\u00e9seau Amylose - publications - centres experts - amyloses cardiaques","og_url":"http:\/\/reseau-amylose.org\/rechercheamylose\/publications\/","og_site_name":"R\u00e9seau Amylose Recherche","article_modified_time":"2022-07-18T12:52:33+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"39 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/reseau-amylose.org\/rechercheamylose\/publications\/","url":"http:\/\/reseau-amylose.org\/rechercheamylose\/publications\/","name":"Publications - R\u00e9seau Amylose Recherche","isPartOf":{"@id":"https:\/\/reseau-amylose.org\/rechercheamylose\/#website"},"datePublished":"2022-07-13T12:11:59+00:00","dateModified":"2022-07-18T12:52:33+00:00","description":"Consultez les articles publi\u00e9s par les experts du R\u00e9seau Amylose - publications - centres experts - amyloses cardiaques","breadcrumb":{"@id":"http:\/\/reseau-amylose.org\/rechercheamylose\/publications\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["http:\/\/reseau-amylose.org\/rechercheamylose\/publications\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/reseau-amylose.org\/rechercheamylose\/publications\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/reseau-amylose.org\/rechercheamylose\/"},{"@type":"ListItem","position":2,"name":"Publications"}]},{"@type":"WebSite","@id":"https:\/\/reseau-amylose.org\/rechercheamylose\/#website","url":"https:\/\/reseau-amylose.org\/rechercheamylose\/","name":"R\u00e9seau Amylose Recherche","description":"Centre de r\u00e9f\u00e9rence des amyloses cardiaques","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/reseau-amylose.org\/rechercheamylose\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/pages\/3440","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/comments?post=3440"}],"version-history":[{"count":19,"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/pages\/3440\/revisions"}],"predecessor-version":[{"id":3467,"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/pages\/3440\/revisions\/3467"}],"wp:attachment":[{"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/media?parent=3440"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/categories?post=3440"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/tags?post=3440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}